VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study

Salvage chemotherapy (CT) for relapsing or refractory small cell lung cancer (SCLC) remains disappointing. In vitro experiments showed that valproic acid increases apoptosis of SCLC cell lines exposed to doxorubicin, vindesine and bis(2-chloroethyl)amine. The primary objective of this phase II study...

Full description

Bibliographic Details
Main Authors: Berghmans, Thierry, Lafitte, Jean-Jacques, Scherpereel, Arnaud, Ameye, Lieveke, Paesmans, Marianne, Meert, Anne-Pascale, Colinet, Benoit, Tulippe, Christian, Willems, Luc, Leclercq, Nathalie, Sculier, Jean-Paul
Format: Online
Language:English
Published: European Respiratory Society 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005117/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005117/

Similar Items